Add to ORKG<p>Supplemental material, Supplementary table 2 Article Inclusion and Exclusion for A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies by Sam Maleki, Marliese Alexander, Tsien Fua, Chen Liu, Danny Rischin and Senthil Lingaratnam in Journal of Oncology Pharmacy Practice</p
Supplementary Figure 1 presents study selection process. Supplementary Figure 2 presents the trends...
Table S2. Reasons for study exclusion from the review at both title and abstract and fulltext screen...
<p>Supplemental material, Supplemental_Table_1 for Evaluating Cancer Patients’ Expectations and Barr...
<p>Supplemental material for A systematic review of the impact of outpatient clinical pharmacy servi...
Supplemental material, Supplemental material2 for Clinical oncology pharmacist: Effective contributi...
Supplemental material, Supplemental material1 for Clinical oncology pharmacist: Effective contributi...
Supplemental Material for Implementation of a student pharmacist-driven medication history service f...
Supplemental material, Supplementary Material for Adherence to oral chemotherapy: Challenges and opp...
Supplemental Material for Barriers to receipt of novel oral oncolytics: A single-institution quality...
Supplemental material, Supplementary_materials_Table_S2_Description_of_risk_of_bias_assessment_by_CL...
Supplemental material, Supplementary_Table_1 for Real-world comparative effectiveness of nab-paclita...
<p>Supplemental material, Appendix for Integration of clinical pharmacists into an ambulatory, pedia...
<p>supplemental_table_1 for A Quality Improvement Initiative to Improve Medication Management in an ...
Supplemental Material, Appendix_1.Centralized_TOC_Pharmacy_Intervention_Tracking_Form for Evaluation...
Supplemental material, Appendix_signif_articles_2018 for Significant Published Articles for Pharmacy...
Supplementary Figure 1 presents study selection process. Supplementary Figure 2 presents the trends...
Table S2. Reasons for study exclusion from the review at both title and abstract and fulltext screen...
<p>Supplemental material, Supplemental_Table_1 for Evaluating Cancer Patients’ Expectations and Barr...
<p>Supplemental material for A systematic review of the impact of outpatient clinical pharmacy servi...
Supplemental material, Supplemental material2 for Clinical oncology pharmacist: Effective contributi...
Supplemental material, Supplemental material1 for Clinical oncology pharmacist: Effective contributi...
Supplemental Material for Implementation of a student pharmacist-driven medication history service f...
Supplemental material, Supplementary Material for Adherence to oral chemotherapy: Challenges and opp...
Supplemental Material for Barriers to receipt of novel oral oncolytics: A single-institution quality...
Supplemental material, Supplementary_materials_Table_S2_Description_of_risk_of_bias_assessment_by_CL...
Supplemental material, Supplementary_Table_1 for Real-world comparative effectiveness of nab-paclita...
<p>Supplemental material, Appendix for Integration of clinical pharmacists into an ambulatory, pedia...
<p>supplemental_table_1 for A Quality Improvement Initiative to Improve Medication Management in an ...
Supplemental Material, Appendix_1.Centralized_TOC_Pharmacy_Intervention_Tracking_Form for Evaluation...
Supplemental material, Appendix_signif_articles_2018 for Significant Published Articles for Pharmacy...
Supplementary Figure 1 presents study selection process. Supplementary Figure 2 presents the trends...
Table S2. Reasons for study exclusion from the review at both title and abstract and fulltext screen...
<p>Supplemental material, Supplemental_Table_1 for Evaluating Cancer Patients’ Expectations and Barr...